
π Pharma & Life Sciences Β· Flowchart
How a pharmaceutical plant handles a manufacturing deviation: report, impact assessment, root cause, CAPA and batch disposition.
Drawing diagramβ¦
GxP deviation and CAPA workflow: an operator reports a deviation in the quality management system. QA classifies it as minor, major or critical and assesses product impact. Major and critical deviations get a root cause investigation (5 Whys, fishbone). Corrective and preventive actions (CAPA) are raised, implemented and checked for effectiveness. QA decides batch disposition: release, rework or reject, then closes the record.
flowchart TD
A[Operator reports deviation in QMS] --> B[QA classifies severity]
B -->|Minor| C[Document and correct] --> H
B -->|Major or Critical| D[Impact assessment on batch]
D --> E[Root cause investigation]
E --> F[Raise CAPA]
F --> G[Implement actions]
G --> H{Batch disposition}
H -->|Release| I[Batch released]
H -->|Rework| J[Rework under protocol] --> H
H -->|Reject| K[Batch destroyed]
I --> L[CAPA effectiveness check]
K --> L
L --> M[Close deviation]The states of a laboratory sample in a LIMS, from collection to reporting and disposal, with rejection and re-testing.
How a suspected side effect reported by a doctor or patient is captured, assessed and reported to the regulator on time (pharmacovigilance).
The systems that run a clinical trial: trial management, electronic data capture, randomisation, drug supply and safety reporting.
How medicine packs are serialised and traced from factory to pharmacy to stop counterfeits: unique codes, aggregation and verification.
How a pharmaceutical company prepares and files a marketing application (dossier) with regulators and handles their queries.
A schema for electronic batch records in pharmaceutical manufacturing: products, master recipes, batches, steps, materials used and deviations.